November 6 (SeeNews) - Emerging markets-focused asset management firm The Rohatyn Group (TRG) said it has invested in Amethist Radiotherapy's business in Romania and four other countries, obtaining co-control of the company alongside the two co-founders.
"TRG’s investment will be used to accelerate the growth of the company across Europe through the roll-up of clinics, the development of greenfield centers and by outsourcing partnerships with hospitals," The Rohatyn Group said in a press release on Tuesday.
You can subscribe to our M&A newsletter here
Amethyst is one of the largest operators of radiotherapy clinics in Europe and provides radiotherapy treatment for most types of common cancers. The company operates nine centers across France, Romania, Italy, Poland and Austria, treating over 10,000 patients per year. It is present in Romania since 2012 and operates two radiotherapy centers in Bucharest and Cluj.
"Amethyst is emblematic of the type of high-growth pan-regional business TRG focuses on across its global business," TRG CEO Nick Rohatyn said.
The value of the investment was not disclosed.
"TRG’s investment, in terms of both capital and expertise expanding corporate footprints, expediates a new phase in the development of Amethyst as we work to bring the highest standards of cancer care to hospitals and clinics and increase access for patient communities to state of the art radiotherapy treatments," Amethyst Radiotherapy co-founder Ludovic Robert said.
Founded in 2002, The Rohatyn Group is an asset management firm with expertise in emerging markets and real assets headquartered in New York, with offices around the globe.
In October last year, Rohatyn Group completed the acquisitions of two retailers of pet supplies in Southeast Europe - Romania's Animax and Slovenia's Mr. Pet.